October 25, 2022 03:11 PM EDTUpdated 04:08 PM
Pharma
FDA+
Manufacturing

Up­dat­ed: Con­t­a­m­i­na­tion is­sues lead to FDA warn­ing let­ter for South Car­oli­na man­u­fac­tur­ing fa­cil­i­ty

Tyler Patchen

News Reporter

A con­tract man­u­fac­tur­ing fa­cil­i­ty in South Car­oli­na that makes a saline so­lu­tion to help re­plen­ish lost wa­ter and salt has been giv­en a warn­ing let­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times